Concepedia

Rosarelis Torres

RT

Statistics

Publications

6

Citations

446

H-Index

6

Active since

2008

Affiliations

Vanda Pharmaceuticals (United States)(Current)

Massanutten Regional Library

Rosarelis Torres is an author at Vanda Pharmaceuticals (United States) specializing in melatonin receptor pharmacology, medicine, and melatonin pharmacology.

Publications per year

2008–2021

6

Publications

6

Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

Steven W. Lockley, Marlene Dressman, Louis Licamele et al. · The Lancet · 2015 · 293 citations

, , +10

Efficacy of Iloperidone in the Treatment of Schizophrenia

Steven G. Potkin, Robert E. Litman, Rosarelis Torres et al. · Journal of Clinical Psychopharmacology · 2008 · 88 citations

, , +17

Clinical assessment of drug–drug interactions of tasimelteon, a novel dual melatonin receptor agonist

Brian W. Ogilvie, Rosarelis Torres, Marlene Dressman et al. · The Journal of Clinical Pharmacology · 2015 · 21 citations · Full text

, , +11

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

Rosarelis Torres, William G. Kramer, Paolo Baroldi · The Journal of Clinical Pharmacology · 2014 · 20 citations · Full text

, , +17

Absolute Bioavailability of Tasimelteon

Rosarelis Torres, Marlene Dressman, William G. Kramer et al. · American Journal of Therapeutics · 2015 · 12 citations · Full text

, , +12

1–5 of 6